![1]()
News
CDC panel: Pause of J&J COVID-19 vaccine to remain for now
April 15, 2021
“Putting this vaccine on pause for those of us that are frontline health care workers has really been devastating.”
News
How some COVID-19 vaccines could cause rare blood clots
April 14, 2021
Six cases of a rare but serious event in patients who got the J&J vaccine are being reviewed.
![1]()
News
Data about COVID-19-related skin manifestations in children continue to emerge
April 14, 2021
Of 50 hospitalized children infected with COVID-19, 18 (36%) fulfilled criteria for Multisystem Inflammatory Syndrome in Children.
![1]()
News
Making a difference
April 14, 2021
For hospitalists who are interested in advocacy, there are many ways to get involved.
![1]()
News
COVID-19 in children: New cases on the rise again
April 14, 2021
Latest trend is starting to look like the beginning of the next surge.
![1]()
News
Arthritis drug may curb myocardial damage in acute STEMI
April 13, 2021
Tocilizumab appears to improve myocardial salvage by helping tamp down the inflammatory overshoot that occurs during infarction and reperfusion.
News
More evidence MIS-C is a delayed response to SARS-CoV-2
April 13, 2021
CDC analysis of the largest cohort of MIS-C cases in the United States to date shows three temporal peaks of diagnoses in the United States and further validates the “prevailing hypothesis that MIS-C is a postinfectious mediated disorder.”
News
Next winter may be rough: Models predict ‘considerable surge’ of COVID
April 13, 2021
“A considerable surge will occur over next winter,” because the new variants are more transmissible, and people will likely relax social distancing and mask wearing.
![1]()
News
FDA, CDC urge pause of J&J COVID vaccine
April 13, 2021
Treatment for traditional blood clots, such as the drug heparin, should not be used for these clots.
News
Novel antiplatelet drug: Hope for efficacy without bleeding?
April 12, 2021
A new antiplatelet drug with a completely novel mechanism of action could hold the promise of delivering the holy grail – reducing cardiac events without increasing bleeding.
